Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History $4.54 -0.12 (-2.58%) Closing price 04:00 PM EasternExtended Trading$4.54 0.00 (0.00%) As of 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics Stock Price Performance 5 Day Performance-6.65%1 Month Performance-9.48%3 Month Performance-45.04%6 Month Performance-68.29%Year-To-Date Performance-42.66%1 Year Performance-69.16% Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address YMAB Stock Chart for Friday, April, 4, 2025 YMAB Chart by TradingViewRemove Ads Y-mAbs Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$4.80$4.66-2.92%$4.74$4.33822,651 shs$210.72 million04/02/2025$4.50$4.80+6.67%$4.82$4.40238,826 shs$217.05 million04/01/2025$4.43$4.50+1.58%$4.52$4.25261,572 shs$203.48 million03/31/2025$4.81$4.43-7.90%$4.74$4.37392,180 shs$200.32 million03/28/2025$4.96$4.81-3.02%$5.25$4.73164,220 shs$217.50 million03/27/2025$4.84$4.96+2.48%$5.01$4.81205,087 shs$224.28 million03/26/2025$5.09$4.84-4.91%$5.09$4.65220,013 shs$218.86 million03/25/2025$5.16$5.09-1.36%$5.19$5.00234,261 shs$230.16 million03/24/2025$5.00$5.16+3.20%$5.32$5.01208,430 shs$233.33 million03/21/2025$4.92$5.00+1.63%$5.02$4.751.14 million shs$226.09 million Get the Latest News and Ratings for YMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$4.90$4.92+0.41%$4.98$4.82262,772 shs$222.47 million03/19/2025$4.54$4.90+7.93%$4.95$4.58242,442 shs$205.29 million03/18/2025$4.76$4.54-4.62%$4.72$4.45304,571 shs$205.29 million03/17/2025$4.67$4.76+1.93%$4.83$4.51236,445 shs$215.24 million03/14/2025$4.73$4.67-1.27%$4.86$4.64211,825 shs$211.17 million03/13/2025$4.91$4.73-3.67%$5.00$4.70198,542 shs$213.88 million03/12/2025$4.94$4.91-0.61%$5.03$4.79216,523 shs$222.02 million03/11/2025$4.76$4.94+3.78%$4.97$4.62338,078 shs$223.38 million03/10/2025$5.16$4.76-7.75%$5.08$4.71442,603 shs$215.24 million03/07/2025$5.25$5.16-1.71%$5.28$5.06323,344 shs$231.11 million03/06/2025$4.85$5.25+8.25%$5.35$4.71380,389 shs$235.14 million03/05/2025$4.96$4.85-2.22%$5.01$4.57560,206 shs$217.23 million03/04/2025$5.19$4.96-4.43%$5.15$4.25657,489 shs$222.15 million03/03/2025$5.56$5.19-6.59%$5.60$5.13429,703 shs$232.46 million Related Companies RCKT Stock Chart XNCR Stock Chart ZYME Stock Chart XERS Stock Chart PAHC Stock Chart GYRE Stock Chart OCS Stock Chart REPL Stock Chart COGT Stock Chart DAWN Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy YMAB Stock Free YMAB Stock Alerts